Ameren (AEE) has been back in the spotlight after pricing a public offering of US$900 million in junior subordinated notes due 2057. This gives investors fresh information about its long term financing approach.
Ameren’s financing move lands after a relatively steady stretch for the stock, with the share price slipping 1.9% over the past 90 days but still recording a 5.3% year to date share price gain and a 10.1% one year total shareholder return. This signals momentum that has been stronger over multiple years than in recent weeks.
Compare Ameren’s latest financing move with a curated group of utilities and infrastructure players by scanning the 39 power grid technology and infrastructure stocks that are now shaping the future of grid reliability and capital deployment.
Ameren’s new junior subordinated notes can be read in two ways. Either they mirror a steady utility footing, or they reflect changing sentiment toward long dated risk. The valuation now has to show which story fits.
Most Popular Narrative: 11.4% Undervalued
Ameren’s most followed narrative pegs fair value at $119.87, above the last close of $106.25, which puts the new junior notes in a broader long term growth story.
Ongoing and future investments in grid modernization, resilience (e.g., smart substations, composite poles, automation), and clean energy resources (wind, solar, batteries) are expected to expand Ameren's regulated rate base at a forecasted 9.2% CAGR, enabling higher allowed returns and improved net margins.
Curious how that rate base build out feeds into the $119.87 fair value? The narrative focuses on steady top line expansion, firmer margins, and a richer future earnings multiple that many investors usually associate with faster growth sectors, not regulated utilities. The full story explains how those pieces fit together across the next decade.
Result: Fair Value of $119.87 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, the Ameren narrative leans heavily on data center demand materializing as planned and on regulators continuing to sign off on large, long dated investment programs.
Find out about the key risks to this Ameren narrative.
Another View: What Our DCF Says About Ameren
The SWS DCF model paints a cooler picture than the upbeat $119.87 fair value narrative. It puts Ameren closer to $95.28 per share, which sits below the recent $106.25 price and points to the stock trading at a premium rather than a discount.
That gap between an 11.4% upside story and a DCF that suggests overvaluation leaves you with a simple question: Which set of assumptions about growth, regulation, and future cash flows feels more realistic for your own thesis on Ameren?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Ameren for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 31 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
Conflicted by Ameren’s mixed signals on value and growth potential? Act quickly, review the full data set and weigh up the 3 key rewards and 2 important warning signs.
Ready For More Ameren-Sized Ideas?
If Ameren has you thinking differently about value and funding, do not stop here. Use the Simply Wall Street Screener to spot your next opportunity before everyone else.
- Target more resilient payouts by scanning the 6 dividend fortresses that focus on income strength and consistency.
- Hunt for quality at a discount by reviewing the 17 high quality undiscovered gems that many investors have not yet priced in.
- Dial down portfolio risk by zeroing in on the 10 resilient stocks with low risk scores that lean on stronger fundamentals and steadier profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com